Concepedia

Publication | Open Access

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis

DOIFull Paper Access

63

Citations

11

References

2021

Year

Kevin Yau, Kento T. Abe, David Naimark, Matthew J. Oliver, Jeffrey Perl, Jerome A. Leis, Shelly Bolotin, Vanessa Tran, Sarah Mullin, Ellen Shadowitz,
JAMA Network Open

Abstract

This study suggests poor immunogenicity 28 days following a single dose of BNT162b2 vaccine in the hemodialysis population, supporting adherence to recommended vaccination schedules and avoiding delay of the second dose in these at-risk individuals.

References

YearCitations

Page 1